 Emily Farrow
Concepts (406)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 15 | 2024 | 99 | 2.690 |
Why?
| | Fibroblast Growth Factors | 13 | 2018 | 30 | 2.360 |
Why?
| | Mutation | 17 | 2024 | 212 | 1.830 |
Why?
| | Humans | 77 | 2024 | 6896 | 1.620 |
Why?
| | Genetic Testing | 12 | 2024 | 87 | 1.510 |
Why?
| | Familial Hypophosphatemic Rickets | 5 | 2014 | 9 | 1.490 |
Why?
| | Phenotype | 20 | 2024 | 257 | 1.270 |
Why?
| | Genetic Variation | 8 | 2024 | 174 | 1.140 |
Why?
| | Genetic Predisposition to Disease | 8 | 2024 | 231 | 1.110 |
Why?
| | Rare Diseases | 5 | 2024 | 48 | 1.060 |
Why?
| | Sequence Analysis, DNA | 12 | 2024 | 115 | 1.050 |
Why?
| | Genomics | 5 | 2024 | 101 | 1.030 |
Why?
| | Genome, Human | 8 | 2024 | 86 | 0.900 |
Why?
| | Male | 33 | 2024 | 3337 | 0.850 |
Why?
| | Genes, Recessive | 5 | 2017 | 6 | 0.840 |
Why?
| | Kidney | 5 | 2012 | 94 | 0.820 |
Why?
| | Female | 36 | 2024 | 3525 | 0.810 |
Why?
| | Alleles | 12 | 2024 | 214 | 0.800 |
Why?
| | Medicine | 1 | 2021 | 10 | 0.780 |
Why?
| | Mutation, Missense | 8 | 2024 | 28 | 0.740 |
Why?
| | Phosphates | 6 | 2014 | 13 | 0.720 |
Why?
| | Calcinosis | 4 | 2018 | 6 | 0.720 |
Why?
| | Glucuronidase | 5 | 2012 | 5 | 0.700 |
Why?
| | Abnormalities, Multiple | 6 | 2018 | 36 | 0.690 |
Why?
| | Dental Enamel Proteins | 1 | 2019 | 1 | 0.670 |
Why?
| | Hypophosphatemia | 4 | 2011 | 5 | 0.670 |
Why?
| | Extracellular Matrix Proteins | 3 | 2011 | 13 | 0.650 |
Why?
| | Child, Preschool | 18 | 2024 | 1569 | 0.620 |
Why?
| | Phosphoproteins | 2 | 2008 | 14 | 0.620 |
Why?
| | Animals | 15 | 2024 | 729 | 0.610 |
Why?
| | Intellectual Disability | 4 | 2022 | 35 | 0.600 |
Why?
| | Laboratories | 3 | 2022 | 14 | 0.590 |
Why?
| | Bone Diseases, Metabolic | 1 | 2016 | 8 | 0.570 |
Why?
| | Child | 24 | 2024 | 3364 | 0.570 |
Why?
| | Exome | 11 | 2022 | 36 | 0.570 |
Why?
| | Glucuronosyltransferase | 1 | 2016 | 16 | 0.560 |
Why?
| | Fractures, Bone | 1 | 2016 | 34 | 0.560 |
Why?
| | Developmental Disabilities | 4 | 2020 | 43 | 0.550 |
Why?
| | Bone and Bones | 5 | 2017 | 17 | 0.530 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2024 | 9 | 0.530 |
Why?
| | Mice | 11 | 2024 | 348 | 0.520 |
Why?
| | MAP Kinase Signaling System | 3 | 2018 | 5 | 0.510 |
Why?
| | N-Acetylgalactosaminyltransferases | 3 | 2011 | 4 | 0.500 |
Why?
| | Base Sequence | 7 | 2024 | 81 | 0.500 |
Why?
| | Infant | 16 | 2024 | 1446 | 0.440 |
Why?
| | Pedigree | 8 | 2024 | 59 | 0.430 |
Why?
| | DNA Methylation | 2 | 2024 | 115 | 0.420 |
Why?
| | Hyperphosphatemia | 4 | 2018 | 10 | 0.410 |
Why?
| | Nervous System Malformations | 2 | 2022 | 6 | 0.400 |
Why?
| | Genetic Diseases, Inborn | 3 | 2018 | 20 | 0.390 |
Why?
| | Epilepsy | 3 | 2016 | 14 | 0.390 |
Why?
| | Mitochondrial Diseases | 3 | 2017 | 4 | 0.380 |
Why?
| | Genome-Wide Association Study | 4 | 2024 | 190 | 0.380 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2010 | 4 | 0.370 |
Why?
| | Wnt Proteins | 1 | 2010 | 11 | 0.370 |
Why?
| | Cell Line | 5 | 2018 | 81 | 0.360 |
Why?
| | Cleft Lip | 3 | 2021 | 7 | 0.360 |
Why?
| | Cleft Palate | 3 | 2021 | 10 | 0.360 |
Why?
| | Autistic Disorder | 2 | 2022 | 14 | 0.360 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2009 | 3 | 0.360 |
Why?
| | Kidney Tubules, Distal | 1 | 2009 | 1 | 0.340 |
Why?
| | Sodium-Phosphate Cotransporter Proteins | 1 | 2009 | 1 | 0.340 |
Why?
| | DNA Mutational Analysis | 7 | 2024 | 42 | 0.320 |
Why?
| | Mice, Inbred C57BL | 6 | 2024 | 92 | 0.320 |
Why?
| | Recombinant Proteins | 3 | 2016 | 48 | 0.320 |
Why?
| | Signal Transduction | 4 | 2018 | 132 | 0.290 |
Why?
| | Databases, Genetic | 2 | 2024 | 30 | 0.290 |
Why?
| | Infant, Newborn | 10 | 2021 | 816 | 0.290 |
Why?
| | Chromosome Mapping | 2 | 2024 | 35 | 0.280 |
Why?
| | Genotype | 5 | 2022 | 410 | 0.280 |
Why?
| | Bone Diseases, Developmental | 1 | 2006 | 3 | 0.270 |
Why?
| | Retrospective Studies | 5 | 2024 | 1296 | 0.260 |
Why?
| | Brain | 5 | 2018 | 80 | 0.260 |
Why?
| | DNA | 3 | 2019 | 41 | 0.250 |
Why?
| | Cysteine Endopeptidases | 1 | 2024 | 3 | 0.240 |
Why?
| | Autoimmunity | 1 | 2024 | 4 | 0.240 |
Why?
| | Multifactorial Inheritance | 1 | 2024 | 17 | 0.240 |
Why?
| | Lysosomes | 1 | 2024 | 2 | 0.240 |
Why?
| | Neurodegenerative Diseases | 1 | 2024 | 2 | 0.240 |
Why?
| | Membrane Transport Proteins | 1 | 2024 | 16 | 0.240 |
Why?
| | Toll-Like Receptors | 1 | 2024 | 14 | 0.240 |
Why?
| | Tandem Repeat Sequences | 1 | 2024 | 7 | 0.230 |
Why?
| | Health Services Accessibility | 1 | 2024 | 39 | 0.230 |
Why?
| | Heterozygote | 4 | 2018 | 26 | 0.230 |
Why?
| | Rural Population | 1 | 2024 | 42 | 0.230 |
Why?
| | Autoimmune Diseases | 2 | 2024 | 13 | 0.220 |
Why?
| | Diverticulitis | 1 | 2023 | 1 | 0.220 |
Why?
| | Diverticulitis, Colonic | 1 | 2023 | 1 | 0.220 |
Why?
| | Ameloblastoma | 1 | 2023 | 2 | 0.220 |
Why?
| | Odontogenic Tumors | 1 | 2023 | 2 | 0.220 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2023 | 2 | 0.220 |
Why?
| | Genetic Association Studies | 3 | 2021 | 53 | 0.220 |
Why?
| | Insurance Coverage | 1 | 2023 | 21 | 0.210 |
Why?
| | Adolescent | 9 | 2020 | 2197 | 0.210 |
Why?
| | Neurodevelopmental Disorders | 1 | 2022 | 23 | 0.210 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 29 | 0.210 |
Why?
| | Cytochrome P-450 CYP2C8 | 1 | 2022 | 3 | 0.200 |
Why?
| | Cytochrome P-450 CYP2C9 | 1 | 2022 | 25 | 0.200 |
Why?
| | Codon, Nonsense | 2 | 2019 | 6 | 0.200 |
Why?
| | Osteocytes | 2 | 2011 | 3 | 0.200 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2022 | 60 | 0.200 |
Why?
| | Gene Expression Regulation | 2 | 2022 | 101 | 0.190 |
Why?
| | Molecular Sequence Annotation | 1 | 2021 | 9 | 0.190 |
Why?
| | Frameshift Mutation | 2 | 2013 | 5 | 0.190 |
Why?
| | Diagnostic Tests, Routine | 2 | 2018 | 19 | 0.190 |
Why?
| | Herpes Simplex | 1 | 2020 | 10 | 0.190 |
Why?
| | Infant, Premature, Diseases | 1 | 2021 | 22 | 0.190 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2020 | 17 | 0.190 |
Why?
| | Microfilament Proteins | 1 | 2020 | 12 | 0.180 |
Why?
| | Sexual Development | 1 | 2020 | 3 | 0.180 |
Why?
| | Karyotyping | 1 | 2020 | 11 | 0.180 |
Why?
| | eIF-2 Kinase | 1 | 2020 | 1 | 0.180 |
Why?
| | Disorders of Sex Development | 1 | 2020 | 10 | 0.180 |
Why?
| | Leukoencephalopathies | 1 | 2020 | 2 | 0.180 |
Why?
| | RNA Polymerase III | 2 | 2018 | 2 | 0.180 |
Why?
| | Protein Structure, Tertiary | 2 | 2011 | 14 | 0.180 |
Why?
| | Genome | 2 | 2022 | 32 | 0.170 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 32 | 0.170 |
Why?
| | Sequence Deletion | 2 | 2016 | 12 | 0.170 |
Why?
| | RNA, Messenger | 4 | 2015 | 115 | 0.170 |
Why?
| | Blood | 1 | 2019 | 10 | 0.170 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2021 | 67 | 0.170 |
Why?
| | Dental Enamel | 1 | 2019 | 1 | 0.170 |
Why?
| | Goldenhar Syndrome | 1 | 2019 | 1 | 0.170 |
Why?
| | Dental Care | 1 | 2019 | 2 | 0.170 |
Why?
| | Hemophilia A | 1 | 2019 | 15 | 0.170 |
Why?
| | Ectodermal Dysplasia | 2 | 2018 | 2 | 0.170 |
Why?
| | Hyperostosis, Cortical, Congenital | 1 | 2018 | 2 | 0.160 |
Why?
| | Pregnancy | 5 | 2020 | 216 | 0.160 |
Why?
| | Autoantibodies | 1 | 2018 | 11 | 0.160 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2018 | 3 | 0.160 |
Why?
| | Premature Birth | 1 | 2018 | 6 | 0.160 |
Why?
| | Tuberous Sclerosis | 1 | 2018 | 4 | 0.160 |
Why?
| | Mice, Knockout | 3 | 2017 | 59 | 0.160 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2018 | 2 | 0.160 |
Why?
| | Cerebellar Ataxia | 1 | 2018 | 4 | 0.160 |
Why?
| | Genes, Dominant | 1 | 2018 | 5 | 0.160 |
Why?
| | Megalencephaly | 1 | 2018 | 3 | 0.160 |
Why?
| | I-kappa B Kinase | 1 | 2018 | 4 | 0.160 |
Why?
| | Optic Atrophy | 1 | 2018 | 1 | 0.150 |
Why?
| | Spinocerebellar Ataxias | 1 | 2018 | 1 | 0.150 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2018 | 2 | 0.150 |
Why?
| | Mitochondria | 2 | 2015 | 11 | 0.150 |
Why?
| | Phosphotransferases | 1 | 2017 | 2 | 0.150 |
Why?
| | Muscle Hypotonia | 1 | 2017 | 7 | 0.150 |
Why?
| | Bone Marrow | 1 | 2017 | 6 | 0.150 |
Why?
| | Transcription Factors | 2 | 2018 | 52 | 0.150 |
Why?
| | Dwarfism | 2 | 2008 | 4 | 0.150 |
Why?
| | Myoclonic Epilepsies, Progressive | 1 | 2017 | 2 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2017 | 8 | 0.150 |
Why?
| | Erythropoietin | 1 | 2017 | 19 | 0.150 |
Why?
| | Peptide Elongation Factors | 1 | 2017 | 1 | 0.150 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 2017 | 1 | 0.150 |
Why?
| | Mandibulofacial Dysostosis | 1 | 2017 | 2 | 0.150 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2017 | 2 | 0.150 |
Why?
| | Seizures | 1 | 2017 | 25 | 0.150 |
Why?
| | Dextromethorphan | 1 | 2017 | 55 | 0.140 |
Why?
| | Protein Folding | 1 | 2016 | 2 | 0.140 |
Why?
| | Microtubules | 1 | 2016 | 5 | 0.140 |
Why?
| | Tubulin | 1 | 2016 | 6 | 0.140 |
Why?
| | Microtubule-Associated Proteins | 1 | 2016 | 5 | 0.140 |
Why?
| | Progeria | 1 | 2016 | 1 | 0.140 |
Why?
| | Fetal Growth Retardation | 1 | 2016 | 2 | 0.140 |
Why?
| | Brain Diseases | 1 | 2016 | 6 | 0.140 |
Why?
| | Cadherins | 1 | 2016 | 7 | 0.140 |
Why?
| | Mosaicism | 1 | 2016 | 9 | 0.140 |
Why?
| | Adult | 6 | 2018 | 1181 | 0.140 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2015 | 38 | 0.130 |
Why?
| | Yersinia Infections | 1 | 2015 | 1 | 0.130 |
Why?
| | Lymphadenitis | 1 | 2015 | 3 | 0.130 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2015 | 3 | 0.130 |
Why?
| | Shab Potassium Channels | 1 | 2015 | 1 | 0.130 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2015 | 1 | 0.130 |
Why?
| | Heterotaxy Syndrome | 1 | 2015 | 1 | 0.130 |
Why?
| | Zebrafish | 3 | 2024 | 10 | 0.130 |
Why?
| | Vertebrates | 1 | 2015 | 4 | 0.130 |
Why?
| | Point Mutation | 1 | 2015 | 7 | 0.130 |
Why?
| | Body Patterning | 1 | 2015 | 8 | 0.130 |
Why?
| | Alstrom Syndrome | 1 | 2015 | 1 | 0.130 |
Why?
| | Parathyroid Hormone | 3 | 2010 | 24 | 0.130 |
Why?
| | DNA Polymerase II | 1 | 2015 | 1 | 0.130 |
Why?
| | DNA Breaks | 1 | 2015 | 2 | 0.130 |
Why?
| | Chromosomal Instability | 1 | 2015 | 2 | 0.130 |
Why?
| | Disease Models, Animal | 2 | 2018 | 71 | 0.130 |
Why?
| | Pneumonia, Aspiration | 1 | 2015 | 8 | 0.130 |
Why?
| | Rats | 2 | 2014 | 106 | 0.130 |
Why?
| | Group IV Phospholipases A2 | 1 | 2015 | 2 | 0.130 |
Why?
| | Polydactyly | 1 | 2015 | 1 | 0.130 |
Why?
| | Proteins | 1 | 2015 | 27 | 0.130 |
Why?
| | Syndactyly | 1 | 2015 | 4 | 0.130 |
Why?
| | Endopeptidase Clp | 1 | 2015 | 1 | 0.130 |
Why?
| | Metabolism, Inborn Errors | 1 | 2015 | 6 | 0.130 |
Why?
| | Group VI Phospholipases A2 | 1 | 2014 | 1 | 0.120 |
Why?
| | Neuroaxonal Dystrophies | 1 | 2014 | 2 | 0.120 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2017 | 184 | 0.120 |
Why?
| | Mice, Mutant Strains | 2 | 2014 | 7 | 0.120 |
Why?
| | Middle Aged | 3 | 2023 | 608 | 0.120 |
Why?
| | Hypothalamic Diseases | 1 | 2013 | 1 | 0.120 |
Why?
| | Microphthalmos | 1 | 2013 | 1 | 0.120 |
Why?
| | Radius | 1 | 2013 | 1 | 0.120 |
Why?
| | Synostosis | 1 | 2013 | 1 | 0.120 |
Why?
| | Holoprosencephaly | 1 | 2013 | 1 | 0.120 |
Why?
| | Hamartoma | 1 | 2013 | 3 | 0.120 |
Why?
| | Mullerian Ducts | 1 | 2013 | 3 | 0.120 |
Why?
| | Femur | 1 | 2013 | 10 | 0.120 |
Why?
| | Protein Transport | 2 | 2015 | 5 | 0.110 |
Why?
| | Pierre Robin Syndrome | 1 | 2013 | 6 | 0.110 |
Why?
| | Microcephaly | 1 | 2013 | 5 | 0.110 |
Why?
| | Genome, Mitochondrial | 1 | 2013 | 2 | 0.110 |
Why?
| | Facies | 3 | 2020 | 3 | 0.110 |
Why?
| | Lung | 1 | 2013 | 65 | 0.110 |
Why?
| | Sequence Analysis, RNA | 1 | 2013 | 26 | 0.110 |
Why?
| | Receptors, Cell Surface | 1 | 2012 | 7 | 0.110 |
Why?
| | Models, Molecular | 2 | 2018 | 14 | 0.110 |
Why?
| | Radiography | 4 | 2015 | 37 | 0.110 |
Why?
| | Young Adult | 4 | 2018 | 647 | 0.110 |
Why?
| | Fibroblasts | 3 | 2018 | 26 | 0.110 |
Why?
| | Early Growth Response Protein 1 | 2 | 2009 | 2 | 0.100 |
Why?
| | Exons | 3 | 2022 | 34 | 0.100 |
Why?
| | Haplotypes | 2 | 2023 | 91 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 71 | 0.100 |
Why?
| | Osteomalacia | 1 | 2011 | 2 | 0.100 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2011 | 5 | 0.100 |
Why?
| | Gene-Environment Interaction | 1 | 2011 | 13 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2011 | 35 | 0.100 |
Why?
| | Syndrome | 3 | 2018 | 34 | 0.100 |
Why?
| | Nuclear Proteins | 2 | 2022 | 52 | 0.100 |
Why?
| | Receptor, Parathyroid Hormone, Type 1 | 1 | 2011 | 2 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 3 | 2018 | 122 | 0.100 |
Why?
| | HEK293 Cells | 2 | 2024 | 32 | 0.100 |
Why?
| | Nerve Tissue Proteins | 2 | 2023 | 26 | 0.100 |
Why?
| | Cohort Studies | 2 | 2024 | 289 | 0.090 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2010 | 1 | 0.090 |
Why?
| | Fatal Outcome | 2 | 2024 | 7 | 0.090 |
Why?
| | DNA Copy Number Variations | 2 | 2022 | 37 | 0.090 |
Why?
| | Cell Cycle Proteins | 2 | 2022 | 18 | 0.080 |
Why?
| | Actins | 1 | 2009 | 5 | 0.080 |
Why?
| | DNA Primers | 1 | 2009 | 30 | 0.080 |
Why?
| | Hyperostosis | 1 | 2008 | 1 | 0.080 |
Why?
| | Subcellular Fractions | 1 | 2008 | 1 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2008 | 5 | 0.080 |
Why?
| | Osteochondrodysplasias | 1 | 2008 | 3 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2008 | 6 | 0.080 |
Why?
| | Vitamin D | 1 | 2008 | 22 | 0.080 |
Why?
| | Bone Development | 1 | 2007 | 4 | 0.080 |
Why?
| | Calcification, Physiologic | 1 | 2007 | 3 | 0.080 |
Why?
| | Codon, Terminator | 1 | 2007 | 2 | 0.080 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2007 | 4 | 0.080 |
Why?
| | Chromosome Disorders | 1 | 2007 | 7 | 0.080 |
Why?
| | Aneuploidy | 1 | 2007 | 4 | 0.080 |
Why?
| | Peptides | 1 | 2007 | 11 | 0.070 |
Why?
| | Ataxia | 2 | 2020 | 2 | 0.070 |
Why?
| | Calcitriol | 3 | 2014 | 6 | 0.070 |
Why?
| | Craniosynostoses | 1 | 2006 | 1 | 0.070 |
Why?
| | Crystallography, X-Ray | 1 | 2006 | 4 | 0.070 |
Why?
| | Protein Conformation | 1 | 2006 | 5 | 0.070 |
Why?
| | Homozygote | 2 | 2017 | 20 | 0.070 |
Why?
| | NIH 3T3 Cells | 2 | 2017 | 5 | 0.060 |
Why?
| | Amino Acid Substitution | 2 | 2016 | 12 | 0.060 |
Why?
| | Penetrance | 1 | 2024 | 8 | 0.060 |
Why?
| | Toll-Like Receptor 7 | 1 | 2024 | 2 | 0.060 |
Why?
| | ADP-Ribosylation Factors | 1 | 2024 | 2 | 0.060 |
Why?
| | Software | 1 | 2024 | 30 | 0.060 |
Why?
| | Molecular Diagnostic Techniques | 2 | 2014 | 38 | 0.060 |
Why?
| | Formaldehyde | 1 | 2023 | 4 | 0.060 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 3 | 0.060 |
Why?
| | Genetic Heterogeneity | 1 | 2023 | 5 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2024 | 199 | 0.050 |
Why?
| | Colonoscopy | 1 | 2023 | 15 | 0.050 |
Why?
| | Survival of Motor Neuron 1 Protein | 1 | 2023 | 2 | 0.050 |
Why?
| | Survival of Motor Neuron 2 Protein | 1 | 2023 | 2 | 0.050 |
Why?
| | Sequence Analysis | 1 | 2023 | 3 | 0.050 |
Why?
| | Face | 1 | 2022 | 3 | 0.050 |
Why?
| | Histone Demethylases | 1 | 2022 | 2 | 0.050 |
Why?
| | Gene Dosage | 1 | 2023 | 13 | 0.050 |
Why?
| | Acute Disease | 1 | 2023 | 79 | 0.050 |
Why?
| | 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2022 | 3 | 0.050 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2022 | 4 | 0.050 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2022 | 7 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2022 | 54 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2023 | 304 | 0.050 |
Why?
| | GPI-Linked Proteins | 1 | 2021 | 1 | 0.050 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2021 | 2 | 0.050 |
Why?
| | Cell Adhesion Molecules | 1 | 2021 | 4 | 0.050 |
Why?
| | Data Accuracy | 1 | 2021 | 6 | 0.050 |
Why?
| | Reference Values | 1 | 2021 | 39 | 0.050 |
Why?
| | Complement C6 | 1 | 2020 | 4 | 0.050 |
Why?
| | Complement C7 | 1 | 2020 | 4 | 0.050 |
Why?
| | RNA Nucleotidyltransferases | 1 | 2020 | 4 | 0.050 |
Why?
| | TNF Receptor-Associated Factor 3 | 1 | 2020 | 4 | 0.050 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2020 | 4 | 0.050 |
Why?
| | Perforin | 1 | 2020 | 4 | 0.050 |
Why?
| | Scavenger Receptors, Class A | 1 | 2020 | 5 | 0.050 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2021 | 9 | 0.050 |
Why?
| | GRB2 Adaptor Protein | 1 | 2020 | 5 | 0.050 |
Why?
| | STAT1 Transcription Factor | 1 | 2020 | 6 | 0.050 |
Why?
| | Toll-Like Receptor 3 | 1 | 2020 | 6 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 39 | 0.050 |
Why?
| | Pilot Projects | 1 | 2020 | 120 | 0.050 |
Why?
| | Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 1 | 0.040 |
Why?
| | White Matter | 1 | 2020 | 6 | 0.040 |
Why?
| | Infant, Premature | 1 | 2021 | 85 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 150 | 0.040 |
Why?
| | Adenosine Diphosphate | 1 | 2018 | 1 | 0.040 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2018 | 4 | 0.040 |
Why?
| | Finland | 1 | 2018 | 11 | 0.040 |
Why?
| | Receptors, Glucocorticoid | 1 | 2018 | 5 | 0.040 |
Why?
| | Pakistan | 1 | 2018 | 5 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2018 | 5 | 0.040 |
Why?
| | Phosphorylation | 1 | 2018 | 22 | 0.040 |
Why?
| | Incidental Findings | 1 | 2018 | 8 | 0.040 |
Why?
| | Larva | 1 | 2018 | 1 | 0.040 |
Why?
| | Purkinje Cells | 1 | 2018 | 2 | 0.040 |
Why?
| | Genetic Complementation Test | 1 | 2018 | 4 | 0.040 |
Why?
| | Family | 1 | 2018 | 27 | 0.040 |
Why?
| | Eyelids | 1 | 2018 | 1 | 0.040 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2018 | 3 | 0.040 |
Why?
| | Interferon Regulatory Factors | 1 | 2018 | 4 | 0.040 |
Why?
| | Microarray Analysis | 1 | 2018 | 6 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2018 | 32 | 0.040 |
Why?
| | Eye Abnormalities | 1 | 2018 | 6 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2018 | 20 | 0.040 |
Why?
| | Muscle Spasticity | 1 | 2018 | 3 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2018 | 34 | 0.040 |
Why?
| | Recurrence | 1 | 2018 | 110 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2018 | 15 | 0.040 |
Why?
| | Epilepsies, Partial | 1 | 2017 | 5 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2018 | 215 | 0.040 |
Why?
| | Gene Frequency | 1 | 2018 | 90 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2018 | 151 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 6 | 0.040 |
Why?
| | Electronic Health Records | 1 | 2018 | 64 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2017 | 22 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2017 | 84 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 94 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 77 | 0.040 |
Why?
| | Spindle Apparatus | 1 | 2016 | 3 | 0.040 |
Why?
| | Molecular Chaperones | 1 | 2016 | 7 | 0.040 |
Why?
| | Risk Factors | 1 | 2018 | 487 | 0.040 |
Why?
| | Age of Onset | 1 | 2016 | 28 | 0.040 |
Why?
| | Protein Binding | 1 | 2016 | 31 | 0.040 |
Why?
| | Prenatal Diagnosis | 1 | 2016 | 14 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 126 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2016 | 58 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2018 | 348 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 15 | 0.030 |
Why?
| | Electroencephalography | 1 | 2016 | 7 | 0.030 |
Why?
| | Cricetulus | 1 | 2015 | 1 | 0.030 |
Why?
| | CHO Cells | 1 | 2015 | 3 | 0.030 |
Why?
| | Cricetinae | 1 | 2015 | 4 | 0.030 |
Why?
| | Ion Channel Gating | 1 | 2015 | 3 | 0.030 |
Why?
| | Action Potentials | 1 | 2015 | 5 | 0.030 |
Why?
| | COS Cells | 1 | 2015 | 19 | 0.030 |
Why?
| | Potassium | 1 | 2015 | 9 | 0.030 |
Why?
| | Genetic Markers | 1 | 2015 | 22 | 0.030 |
Why?
| | Zebrafish Proteins | 1 | 2015 | 1 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2015 | 11 | 0.030 |
Why?
| | Family Health | 1 | 2015 | 14 | 0.030 |
Why?
| | Embryo, Nonmammalian | 1 | 2015 | 9 | 0.030 |
Why?
| | Heart | 1 | 2015 | 14 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 51 | 0.030 |
Why?
| | Chronic Disease | 1 | 2015 | 105 | 0.030 |
Why?
| | Critical Illness | 1 | 2015 | 22 | 0.030 |
Why?
| | Cranial Fontanelles | 1 | 2015 | 1 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 16 | 0.030 |
Why?
| | Cataract | 1 | 2015 | 1 | 0.030 |
Why?
| | Greenland | 1 | 2015 | 1 | 0.030 |
Why?
| | Atrophy | 1 | 2015 | 6 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2015 | 9 | 0.030 |
Why?
| | Movement Disorders | 1 | 2015 | 4 | 0.030 |
Why?
| | Calcium | 1 | 2015 | 41 | 0.030 |
Why?
| | Neutropenia | 1 | 2015 | 12 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 71 | 0.030 |
Why?
| | Health Care Costs | 1 | 2014 | 33 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2014 | 20 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2015 | 81 | 0.030 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2014 | 3 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 4 | 0.030 |
Why?
| | Steroid Hydroxylases | 1 | 2014 | 10 | 0.030 |
Why?
| | Iron | 1 | 2014 | 14 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 50 | 0.030 |
Why?
| | Liver | 1 | 2015 | 126 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2014 | 32 | 0.030 |
Why?
| | Diet | 1 | 2014 | 52 | 0.030 |
Why?
| | Leigh Disease | 1 | 2013 | 1 | 0.030 |
Why?
| | Ubiquinone | 1 | 2013 | 1 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2013 | 1 | 0.030 |
Why?
| | Muscle Weakness | 1 | 2013 | 2 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2012 | 12 | 0.030 |
Why?
| | Organ Specificity | 1 | 2012 | 23 | 0.030 |
Why?
| | Connexins | 1 | 2012 | 3 | 0.030 |
Why?
| | Gene Expression | 1 | 2012 | 67 | 0.030 |
Why?
| | Bone Density | 1 | 2012 | 43 | 0.030 |
Why?
| | Absorption | 1 | 2011 | 7 | 0.020 |
Why?
| | Up-Regulation | 1 | 2011 | 25 | 0.020 |
Why?
| | Models, Biological | 1 | 2011 | 65 | 0.020 |
Why?
| | Niacinamide | 1 | 2008 | 1 | 0.020 |
Why?
| | Diuretics | 1 | 2008 | 4 | 0.020 |
Why?
| | Acetazolamide | 1 | 2008 | 2 | 0.020 |
Why?
| | Vitamin B Complex | 1 | 2008 | 2 | 0.020 |
Why?
| | Hip Joint | 1 | 2008 | 4 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 17 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 2 | 0.020 |
Why?
| | Molecular Biology | 1 | 2008 | 3 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2008 | 19 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2007 | 12 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|